Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 213 (representing 44 labs)

Tests names and labsConditionsGenes and analytesMethods

CentoColon extended panel

Centogene AG - the Rare Disease Company
Germany
1917
  • C Sequence analysis of the entire coding region

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

FoundationOne®

Foundation Medicine, Inc.
United States
1315
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Otogenetics Hereditary Cancers

Otogenetics
United States
3639
  • E Sequence analysis of select exons

MMR genes methylation analysis

Centogene AG - the Rare Disease Company
Germany
17
  • D Deletion/duplication analysis

Hereditary Cancer Panel - High Penetrance 16

Molecular Genetics Laboratory London Health Sciences Centre
Canada
2816
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel Comprehensive

Molecular Genetics Laboratory London Health Sciences Centre
Canada
4030
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Colorectal cancer, hereditary nonpolyposis type 4

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

qCancer Risk Expanded

Quantitative Genomic Medicine Laboratories, SL
Spain
145
  • C Sequence analysis of the entire coding region

qCancer Risk

Quantitative Genomic Medicine Laboratories, SL
Spain
130
  • C Sequence analysis of the entire coding region

BrainTumorNext

Ambry Genetics
United States
7727
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CustomNext-Cancer

Ambry Genetics
United States
6867
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Vistaseq Hereditary Cancer Panel Without BRCA

Molecular Diagnostic Laboratory LabCorp
United States
1725
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

VistaSeq Hereditary Cancer Panel

Molecular Diagnostic Laboratory LabCorp
United States
1827
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PMS2 Comprehensive Analysis

Molecular Diagnostic Laboratory LabCorp
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PMS2 Deletion/Duplication Analysis

Molecular Diagnostic Laboratory LabCorp
United States
11
  • D Deletion/duplication analysis

MLH1/MSH2/MSH6/PMS2 Comprehensive Analysis

Molecular Diagnostic Laboratory LabCorp
United States
14
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Nonpolyposis Colorectal Cander (HNPCC): PMS2 (Known Mutation)

Molecular Diagnostic Laboratory LabCorp
United States
11
  • E Sequence analysis of select exons

myRisk Hereditary Cancer

Myriad Genetic Laboratories, Inc.
United States
1928
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Colon and Endometrial Cancer-ColoNGS

GeneKor MSA
Greece
107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 20 of 213

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center